A study comparing the effects of rosiglitazone and/or insulin treatments on streptozotocin induced diabetic (type I diabetes) rat aorta and cavernous tissues

European Journal of Pharmacology

Volumn 660, Issue 2-3, 2011, Pages 476-484

  Elçioǧlu, H Kübra ^a   Kabasakal, Levent ^a   Özkan, Naziye ^b   Çelikel, Çiǧdem ^b   Ayanoǧlu Dülger, Gül ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Aorta; Corpus cavernosum; Insulin; Rosiglitazone; Streptozotosin

Indexed keywords

GLUTATHIONE; INSULIN; MALONALDEHYDE; ROSIGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA DISEASE; AORTA INFLAMMATION; ARTICLE; CONTROLLED STUDY; CORPUS CAVERNOSUM; DRUG EFFECT; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; OXIDATIVE STRESS; PENIS DISEASE; PENIS INFLAMMATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; STREPTOZOCIN DIABETES; TISSUE SECTION; TREATMENT DURATION; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; BLOOD GLUCOSE; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GLUTATHIONE; INFLAMMATION; INSULIN; LIPID PEROXIDATION; MALE; MUSCLE RELAXATION; PENIS; RATS; THIAZOLIDINEDIONES;

EID: 79956086521     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.03.030     Document Type: Article

References (47)

1. Abdin, A.A., Baalash, A.A., Hamooda, H.E., 2010. Effects of rosiglitazone and aspirin on experimental model of induced type 2 diabetes in rats: focus on insulin resistance and inflammatory markers. J Diabetes Complications 24, 168-178.
2. Anderson, R.G.W., 1998. The caveolae membrane system. Annu. Rev. Biochem. 67, 199-225.
3. Azadzoi, K.M., Saenz, D.T.I., 1992. Diabetes mellitus impairs Neutrogena and endothelium-dependent relaxation of rabbit corpus cavernosum smooth muscle. J. Urol. 148, 1587-1592.
4. Baron, A.D., Clark, M.G., 1997. Role of blood flow in the regulation of muscle glucose uptake. Annu Rev Nutr 17, 487-499. (Pubitemid 27328810)
5. Beuge, J.A., Aust, S.D., 1978. Microsomal lipid peroxidation. Meth. Enzym. 52, 302-311.
6. Beutler, E., 1975. Glutathione in red blood cell metabolism. A mannual Biochemical Methods. Grune&Strattonb, New york, pp. 112-114.
7. Bucci, M., Roviezzo, F., Brancaelone, V., Lin, M.I., Lorenzo, A.D., Cicala, C., Pinto, A., Sessa, W.C., Farneti, S., Fiorucci, S., Cirino, G., 2004. Diabetic mouse angiopathy is linked to progressive sympathetic receptor deletion coupled to an enhanced caveolin-1 expression. Arterioscl. Thromb. Vasc. Biol. 24, 721-726.
8. Calles-Escandon, J., Cipolla, M., 2002. Diabetes and endothelial dysfunction: a clinical perspective. Endocr. Rev. 22, 36-52.
9. Cartledge, J.J., Eardley, I., Morrison, J.F.B., 2000. Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human hemoglobin. Br. J. Urol. Int. 85, 735-741.
10. Cartledge, J.J., Eardley, I., Morrison, J.F.B., 2001. Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes. Br. J. Urol. Int. 87, 402-407.
11. Chinetti-Gbaguidi, G., Fruchart, J.C., Staels, B., 2005. Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy. Curr. Op. Pharmacol. 5, 1-7.
12. Dandona, P., Aljada, A., 2002. A rational approach to pathogenesis and treatment of Type 2 Diabetes mellitus, insulin resistance, inflammation, and atherosclerosis. Am. J. Cardiol. 90, 27G-33G.
13. Dandona, P., Aljada, A., 2004. Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents. J. Diabetes Complicat. 18, 91-102. (Pubitemid 38553939)
14. Dandona, P., Aljada, A., Bandyopadhyay, A., 2004. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7. (Pubitemid 38032801)
15. Desmet, C., Warzee, B., Gosset, P., Melotte, D., Rongvaux, A., Gillet, L., Fievez, L., Seumois, G., Vanderplasschen, A., Staels, B., Lekeux, P., Bureau, F., 2005. Pro-inflammatory properties for thiazolidinediones. Biochem. Pharmacol. 69, 255-265.
16. Elçioǧlu, K., Kabasakal, L., Çetinel, Ş., Conturk, G., Sezen, F.S., Ayanoǧlu-Dülger, G., 2010. Changes in caveolin-1 expression and vasoreactivity in the aorta and corpus cavernosum of the fructose and streptozotocin induced diabetic rats. Eur. J. Pharmacol. 642, 113-120.
17. Heygate, K.M., Lawrence, I.G., Bennett, M.A., Thurston, H., 1995. Impaired endothelium-dependent relaxation in isolated resistance arteries of spontaneously diabetic rats. Br. J. Pharmacol. 116, 3251-3259.
18. Khan, M.A., Thompson, C.S., Jeremy, J.Y., Mumtaz, F.H., Mikhailidis, P., Morgan, R.J., 2001. The effect of superoxide dismutase on nitric oxide-mediated and electrical field-stimulated diabetic rabbit cavernosal smooth muscle relaxation. Br. J. Urol. Int. 87, 98-103.
19. Kim, J., Montagnani, M., Koh, K.K., Quon, M.J., 2006. Reciprocal relationships between Insulin resistance and endothelial dysfunction. Molecular and pathophysiological mechanisms. Circulation 113, 1888-1904.
20. Kobayashi, T., Kamata, K., 1999. Effect of insulin treatment on smooth muscle contractility and endothelium-dependent relaxation in rat aortae from established STZ-induced diabetes. Br. J. Pharmacol. 127, 835-842.
21. Lam, T.Y., Seto, S.W., Lau, Y.M., Au, L.S., Kwan, Y.W., Ngai, S.M., Tsui, K.W., 2006. Impairment of the vascular relaxation and differential expression of caveolin-1 of the aorta of diabetic+db/+db mice. Eur. J. Pharmacol. 546, 134-141.
22. Ling, H.Y., Feng, S.D., Zhou, S.D., Wang, B.X., Liu, X.Q., Hu, B., 2005. Effects of rosiglitazone on aortic function in rats with insulin resistant-hypertension. Acta Phys. Sin. 57, 125-131.
23. Matsumoto, T., Yoshiyama, S., Wakabayashi, K., Kobayashi, T., Kamata, K., 2004. Effects of chronic insulin on endothelial dysfunction of basilar arteries from established streptozotocin-diabetic rats. Eur. J. Pharmacol. 504, 119-127.
24. Miatello, R., Vazquez, M., Renna, N., Cruazodom, M., Zumino, A.P., Risler, N., 2005. Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats. Am. J. Hypertens. 18, 864-870.
25. Muniyappa, R., Quon, M.J., 2007. Insulin action and insulin resistance in vascular endothelium. Curr. Opin. Clin. Nutr. Metab. Care 10, 523-530.
26. Muniyappa, R., Montagnani, M., Koh, K.K., Quon, M.J., 2007. Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.
27. Musicki, B., Burnett, A.L., 2006. Endothelial dysfunction in diabetic erectile dysfunction. Int. J. Impot. Res. 1-10.
28. Nyby, M.D., Matsumoto, K., Yamamoto, K., Abedi, K., Eslami, P., Hernandez, G., Smutko, V., Berger, M.E., Tuck, M.L., 2005. Dietary fish oil prevents vascular dysfunction and oxidative stress in hyperinsulinemic rats. Am. J. Hypertens. 18, 213-219.
29. Paskaloǧlu, K., Şener, G., Ayanoǧlu-Dülger, G., 2004. Melatonin treatment protects against diabetes induced functional and biochemical changes in rat aorta and corpus cavernosum. Eur. J. Pharmacol. 499, 345-354.
30. Pieper, G.M., 1997. Divergent actions of chronic insulin treatment in vivo versus acute treatment ex vivo on diabetic-induced endothelial dysfunction. Life Sci. 60, PL371-PL376.
31. Pistrosch, F., Passauer, J., Fischer, S., Fuecker, K., Hanefeld, M., Gross, P., 2004. In type 2 diabetes, Rosiglitazone therapy for insulin resistance ameliorates endothelial dysfunction independent of glucose control. Diabetes Care 27, 484-490.
32. Quon, M.J., 2006. Reciprocal relationships between insulin resistance and endothelial dysfunction: insights therapeutic interventions. Zhong Nan Da Xue Xue Bao. Yi Xue Ban 31, 305-312. (Pubitemid 44048711)
33. Shakirova, Y., Hedlund, P., Sward, K., 2009. Impaired nerve-mediated relaxation of penile tissue from caveolin-1 deficient mice. Eur. J. Pharmacol. 602, 399-405.
34. 2 - imbalance in insulin-resistant rat aorta. Diabetes 48, 2437-2445.
35. Shinozaki, K., Nishio, Y., Okamura, T., Yoshida, Y., Maegawa, H., Kojima, H., Masada, M., Toda, N., Kikkawa, R., Kashiwagi, A., 2000. Oral administration of tetrahydrobiopterin prevents endothelial dysfunction and vascular oxidative stress in the aortas of insulin-resistant rats. Circ. Res. 87, 566-573.
36. Sjöholm, A., Nyström, T., 2005. Endothelial inflammation in insulin resistance. Lancet 365, 610-612. (Pubitemid 40247919)
37. Sullivan, M., Thompson, C.S., Mikhailidis, D.P., Morgan, R.J., Angelini, G.D., Jeremy, J.Y., 1998. Differential alterations of prostacyclin, cyclic AMP and cyclic GMP formation in the corpus cavernosum of the diabetic rat. Br. J. Urol. 82, 578-584.
38. Szalkowski, D., White-Carrington, S., Berger, J., Zhang, B., 1995. Antidiabetic thiazolidinediones block the inhibitory effect of tumour necrosis factor-a on differentiation, insulin-stimulated glucose uptake and gene expression in 3T3-L1 cells. Endocrinology 136, 1474-1481.
39. Taylor, P.D., McCarthy, A.L., Thomas, C.R., Poston, L., 1992. Endothelium-dependent relaxation and noradrenalin sensitivity in mesenteric resistance arteries of steptozotocin-induced diabetic rats. Br. J. Pharmacol. 107, 393-399.
40. Tesfamariam, B., Palacino, J.J., Weisbrod, R.M., Cohen, R.A., 1993. Aldose reductase inhibition restores endothelial cell function in diabetic rabbit aorta. J. Cardiovasc. Pharm. 21, 205-211.
41. Ugochukwu, N.H., Figgers, C.L., 2007. Caloric restriction inhibits up-regulation of inflammatory cytokines and TNF-α, and activates IL-10 and haptoglobin in the plasma of streptozotocin-induced diabetic rats. J. Nutr. Biochem. 18, 120-126.
42. Vriese, A.D., Verbeuren, T.J., Voorde, J.V., Lameire, N.H., Vanhoutte, P.M., 2000. Endothelial dysfunction in diabetes. Br. J. Pharmacol. 130, 963-974.
43. Walker, A.B., Naderali, E.K., Chattington, P.D., Buckingham, R.E., Williams, G., 1998. Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL49653) and Troglitazone on human small arteries in vitro. Diabetes 47, 810-814. (Pubitemid 28201812)
44. Walker, A.B., Chattington, P.D., Buckingham, R.E., Williams, G., 1999. The thiazolidinedione Rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in zucker fatty rats. Diabetes 48, 1448-1453. (Pubitemid 29297309)
45. Wang, S., Jiang, J.L., Hu, C.P., Zhang, X.J., Yand, D.L., Li, Y.J., 2007. Relationship between protective effects of rosigliatzone on endothelium and endogenous nitric oxide synthase inhibitor in streptozotocin-induced diabetic rats and cultured endothelial cells. Diabetes Metab. Res. Rev. 23, 157-164.
46. Wellen, K.E., Hotamisligil, G.S., 2005. Inflammation, stress, and diabetes. J. Clin. Invest. 115, 1111-1119.
47. Yildirim, S., Ayan, S., Sarioǧlu, Y., Gültekin, Y., Bütünet, C., 1999. The effects of long term oral administration of L-arginine on the erectile response of rabbits with alloxan induced diabetes. Br. J. Urol. Int. 83, 679-685.